oral conventional vitamin B12 in enhancing circulatory B12 levels in healthy deficient adults: a multicentre, double-blind randomized clinical trial
BPC157: Usually given as a small shot under the skin near the sore area
AOD-9604 can be administered via subcutaneous injection or orally, depending on the formulation available
After 72 weeks of treatment: 5 mg dose: 15.0% mean body weight reduction 10 mg dose: 19.5% mean body weight reduction 15 mg dose: 20.9% mean body weight reduction Placebo: 3.1% mean body weight reduction Among participants receiving 15 mg, approximately 57% achieved at least 20% weight loss
Regular injections can help address deficiencies and boost overall vitality
DSIP is ideal for individuals experiencing insufficient deep sleep despite adequate total sleep time, difficulty falling asleep or maintaining sleep, poor sleep quality affecting daytime function, recovery challenges in athletic or high-performance contexts, circadian rhythm disruption from travel or shift work, or age-related sleep quality decline